Makers Laboratories has notified the stock exchange of an upcoming Board of Directors meeting, scheduled for Tuesday, May 26, 2026, pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting has been convened to consider and take on record the audited financial results for the 4th quarter and financial year ended March 31, 2026.

Board Meeting Details

The intimation was filed on May 5, 2026, and signed by Piyush Ajmera, Company Secretary (ACS 58712), on behalf of Makers Laboratories Limited. The key details of the scheduled board meeting are outlined below:

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company had previously communicated via a letter dated March 16, 2026, that the trading window for dealing in the securities of the company by insiders would remain closed. The relevant details are as follows:

The trading window closure ensures that designated insiders are restricted from transacting in the company's securities during the period leading up to and immediately following the announcement of audited financial results, in line with regulatory requirements.

Regulatory Compliance

The board meeting intimation has been filed in compliance with applicable SEBI listing regulations. The company's Company Secretary, Piyush Ajmera (ACS 58712), has formally communicated this notice to BSE Ltd. at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400 023, through online filing.

Makers laboratories Limited has filed its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The pharmaceutical company submitted the mandatory documentation to BSE on April 6, 2026, fulfilling its regulatory obligations under the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Regulatory Filing Details

The certificate was signed and submitted by Piyush Ajmera, Company Secretary & Compliance Officer of Makers Laboratories Limited. The filing was made through the online system to BSE, with the company trading under scrip code 506919.

Registrar Confirmation Certificate

The submission includes a certificate from MUFG Intime India Private Limited (formerly Link Intime India Private Limited), the company's registrar and share transfer agent. The certificate, dated April 3, 2026, was issued by Ashok Shetty, Sr. Vice President-Corporate Registry.

Compliance Confirmations

MUFG Intime India confirmed several key compliance aspects for the quarter:

• Securities received from depository participants for dematerialisation during Q4FY26 were properly confirmed to depositories
• All securities comprised in certificates have been listed on stock exchanges where previously issued securities are listed
• Security certificates received for dematerialisation were confirmed or rejected within prescribed timelines
• Received certificates were mutilated and cancelled after due verification by depository participants
• Depository names were substituted in the register of members as registered owners within required timeframes

About MUFG Intime India

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as the registrar and share transfer agent for Makers Laboratories Limited. The company operates from its registered address at C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083, and holds CIN: U67190MH1999PTC118368.

This quarterly filing demonstrates Makers Laboratories Limited's continued adherence to SEBI's regulatory framework governing depositories and participants, ensuring proper handling of dematerialised securities and maintaining transparency in share transfer processes.